Stephens lowered shares of Envision Healthcare Corporation (NYSE:EVHC) from an overweight rating to an equal weight rating in a report published on Thursday morning. The brokerage currently has $32.00 price target on the stock.

Other analysts also recently issued reports about the company. Zacks Investment Research upgraded Envision Healthcare Corporation from a sell rating to a hold rating in a report on Friday, August 11th. Mizuho dropped their price objective on Envision Healthcare Corporation from $65.00 to $57.00 and set a neutral rating for the company in a report on Wednesday, August 9th. BidaskClub downgraded Envision Healthcare Corporation from a sell rating to a strong sell rating in a report on Thursday, August 17th. Bank of America Corporation downgraded Envision Healthcare Corporation from a buy rating to a neutral rating and set a $32.00 price objective for the company. in a report on Thursday. Finally, Jefferies Group LLC set a $71.00 price objective on Envision Healthcare Corporation and gave the stock a buy rating in a report on Wednesday. Two investment analysts have rated the stock with a sell rating, five have given a hold rating, ten have given a buy rating and one has given a strong buy rating to the company’s stock. Envision Healthcare Corporation currently has an average rating of Buy and an average target price of $49.21.

Envision Healthcare Corporation (EVHC) traded down $0.21 during mid-day trading on Thursday, hitting $27.04. The stock had a trading volume of 4,795,013 shares, compared to its average volume of 5,488,916. The firm has a market cap of $3,267.14, a P/E ratio of 8.35, a price-to-earnings-growth ratio of 0.57 and a beta of 0.69. The company has a current ratio of 3.01, a quick ratio of 2.82 and a debt-to-equity ratio of 0.89. Envision Healthcare Corporation has a 1-year low of $26.56 and a 1-year high of $74.75.

Envision Healthcare Corporation (NYSE:EVHC) last released its quarterly earnings data on Tuesday, October 31st. The company reported $0.73 EPS for the quarter, missing analysts’ consensus estimates of $0.81 by ($0.08). The firm had revenue of $1.99 billion for the quarter, compared to analyst estimates of $2.03 billion. Envision Healthcare Corporation had a positive return on equity of 4.88% and a negative net margin of 6.39%. The company’s quarterly revenue was up 142.0% on a year-over-year basis. During the same quarter in the previous year, the company earned $1.13 earnings per share. equities analysts forecast that Envision Healthcare Corporation will post 3.12 earnings per share for the current year.

COPYRIGHT VIOLATION WARNING: This news story was posted by Watch List News and is the sole property of of Watch List News. If you are viewing this news story on another publication, it was illegally stolen and reposted in violation of U.S. & international trademark & copyright laws. The correct version of this news story can be read at https://www.watchlistnews.com/envision-healthcare-corporation-evhc-downgraded-to-equal-weight-at-stephens/1681289.html.

Envision Healthcare Corporation declared that its board has authorized a share repurchase plan on Monday, September 18th that permits the company to repurchase $250.00 million in shares. This repurchase authorization permits the company to purchase up to 4.5% of its shares through open market purchases. Shares repurchase plans are often an indication that the company’s board of directors believes its stock is undervalued.

A number of large investors have recently bought and sold shares of the business. BNP Paribas Arbitrage SA boosted its position in Envision Healthcare Corporation by 51.2% in the 3rd quarter. BNP Paribas Arbitrage SA now owns 71,960 shares of the company’s stock valued at $3,235,000 after buying an additional 24,366 shares during the last quarter. GHP Investment Advisors Inc. boosted its position in Envision Healthcare Corporation by 21.5% in the 3rd quarter. GHP Investment Advisors Inc. now owns 23,919 shares of the company’s stock valued at $1,075,000 after buying an additional 4,234 shares during the last quarter. Swiss National Bank boosted its position in Envision Healthcare Corporation by 1.2% in the 3rd quarter. Swiss National Bank now owns 432,916 shares of the company’s stock valued at $19,460,000 after buying an additional 5,200 shares during the last quarter. Principal Financial Group Inc. boosted its position in Envision Healthcare Corporation by 1.6% in the 3rd quarter. Principal Financial Group Inc. now owns 182,296 shares of the company’s stock valued at $8,194,000 after buying an additional 2,799 shares during the last quarter. Finally, Oregon Public Employees Retirement Fund boosted its position in Envision Healthcare Corporation by 114.3% in the 3rd quarter. Oregon Public Employees Retirement Fund now owns 26,353 shares of the company’s stock valued at $1,185,000 after buying an additional 14,053 shares during the last quarter.

Envision Healthcare Corporation Company Profile

Envision Healthcare Holdings, Inc, formerly CDRT Holding Corporation, is a holding company. The Company, through its subsidiary, provides physician-led medical services in the United States. It operates in two segments: EmCare Holdings, Inc (EmCare) and American Medical Response, Inc (AMR). Its EmCare segment is a provider of integrated facility-based and post-acute care physician services to healthcare facilities in the United States.

Analyst Recommendations for Envision Healthcare Corporation (NYSE:EVHC)

Receive News & Ratings for Envision Healthcare Corporation Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Envision Healthcare Corporation and related companies with Analyst Ratings Network's FREE daily email newsletter.